Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations

Fingerprint Dive into the research topics of 'Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences